Published in J Neuropathol Exp Neurol on December 01, 2001
Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med (2007) 6.19
Glial influence on the blood brain barrier. Glia (2013) 1.12
The blood-brain barrier. Cold Spring Harb Perspect Biol (2015) 1.00
The regulation of the CNS innate immune response is vital for the restoration of tissue homeostasis (repair) after acute brain injury: a brief review. Int J Inflam (2010) 0.99
Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state. Clin Exp Immunol (2006) 0.93
Intercellular adhesion molecule 1 mediates migration of Th1 and Th17 cells across human retinal vascular endothelium. Invest Ophthalmol Vis Sci (2013) 0.89
Retinal Macroglial Responses in Health and Disease. Biomed Res Int (2016) 0.85
Populations of human T lymphocytes that traverse the vascular endothelium stimulated by Borrelia burgdorferi are enriched with cells that secrete gamma interferon. Infect Immun (2004) 0.83
The Role of Th17 in Neuroimmune Disorders: Target for CAM Therapy. Part II. Evid Based Complement Alternat Med (2011) 0.80
Age-associated physiological and pathological changes at the blood-brain barrier: A review. J Cereb Blood Flow Metab (2016) 0.80
Regulation of vacuolar H(+)-ATPase in microglia by RANKL. Biochem Biophys Res Commun (2009) 0.78
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41
Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev Dyn (1992) 3.14
Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol (2001) 2.75
Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J Neurol (2001) 1.91
Inositol stereoisomers stabilize an oligomeric aggregate of Alzheimer amyloid beta peptide and inhibit abeta -induced toxicity. J Biol Chem (2000) 1.76
Atrial right-to-left shunting causing severe hypoxaemia despite normal right-sided pressures. Report of 11 consecutive cases corrected by percutaneous closure. Eur Heart J (2000) 1.73
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain (1998) 1.71
Brain-immune connection: immuno-regulatory properties of CNS-resident cells. Glia (2000) 1.70
Imaging axonal damage of normal-appearing white matter in multiple sclerosis. Brain (1998) 1.68
Nucleotide sequence of the Paramecium primaurelia G surface protein. A huge protein with a highly periodic structure. J Mol Biol (1986) 1.65
Peripheral blood gamma-delta T cells lyse fresh human brain-derived oligodendrocytes. Ann Neurol (1991) 1.54
Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med (1996) 1.53
Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol (1996) 1.51
Microemboli in cerebral circulation and alteration of cognitive abilities in patients with mechanical prosthetic heart valves. Stroke (1998) 1.51
Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain. Neuropathol Appl Neurobiol (2011) 1.47
Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumors. Ann Oncol (2013) 1.46
Inhibition of growth of established human glioma cell lines by modulators of the protein kinase-C system. J Neurosurg (1990) 1.46
Telomeric site position heterogeneity in macronuclear DNA of Paramecium primaurelia. Nucleic Acids Res (1987) 1.45
N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration. EMBO J (2001) 1.44
Neuroleukin: a lymphokine product of lectin-stimulated T cells. Science (1986) 1.44
PK11195 binding to the peripheral benzodiazepine receptor as a marker of microglia activation in multiple sclerosis and experimental autoimmune encephalomyelitis. J Neurosci Res (1997) 1.43
Prospective serial analysis of interleukin-2 and soluble interleukin-2 receptor in relapsing-remitting multiple sclerosis. Neurology (1992) 1.42
Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology (2000) 1.42
[Susceptibility to measles, rubella and parotitis in young adults]. Med Clin (Barc) (1996) 1.38
[Excess length of stay attributable to nosocomial bacteremia: usefulness of the Hospitalization Appropriateness Protocol]. Med Clin (Barc) (1999) 1.38
[Clinical epidemiology of an outbreak of nosocomial infection caused by Staphylococcus aureus resistant to methicillin and aminoglycosides: efficacy of control measures. Comité de Control de Infecciones]. Med Clin (Barc) (1993) 1.38
Amyotrophic lateral sclerosis and life-sustaining therapy: patients' desires for information, participation in decision making, and life-sustaining therapy. Mayo Clin Proc (1991) 1.37
Glial cell influence on the human blood-brain barrier. Glia (2001) 1.36
Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia (1996) 1.35
Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol (1997) 1.27
Gamma-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci U S A (1991) 1.27
N-arginine dibasic convertase, a metalloendopeptidase as a prototype of a class of processing enzymes. Proc Natl Acad Sci U S A (1994) 1.26
MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J Immunol (1998) 1.26
Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Ann Neurol (1992) 1.24
Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis. N Engl J Med (1984) 1.23
Covered stents in the treatment of peripheral arterial aneurysms: procedural results and midterm follow-up. Cardiovasc Intervent Radiol (1999) 1.21
Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assay. Clin Immunol (2010) 1.20
Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. J Neuropathol Exp Neurol (1992) 1.19
Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo. Neurology (1994) 1.18
In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis. Brain (1999) 1.17
Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol (1998) 1.17
Suppressor cell function in multiple sclerosis: correlation with clinical disease activity. Ann Neurol (1979) 1.17
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells. Glia (2007) 1.16
Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Ann Neurol (1997) 1.15
Chronic traumatic aneurysms of the descending thoracic aorta (19 cases). J Cardiovasc Surg (Torino) (1986) 1.13
Circulating suppressor cells in man as a function of age. Clin Immunol Immunopathol (1978) 1.13
Amyotrophic lateral sclerosis with antecedent poliomyelitis. Arch Neurol (1980) 1.13
Bilateral juxtapapillary subretinal neovascularization associated with pseudotumor cerebri. Am J Ophthalmol (1981) 1.12
Regulation of CD14 expression on human adult central nervous system-derived microglia. J Neurosci Res (1996) 1.11
Inhibition of medulloblastoma cell invasion by Slit. Oncogene (2006) 1.09
Changes in concanavalin A capping of human lymphocytes with age. Mech Ageing Dev (1980) 1.09
Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis. Semin Neurol (1998) 1.08
Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol (1995) 1.04
Baker's yeast, the new work horse in protein synthesis studies: analyzing eukaryotic translation initiation. Bioessays (1990) 1.04
A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J Neurobiol (1995) 1.04
B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur J Immunol (1994) 1.03
Soluble tumor necrosis factor receptor inhibits interleukin 12 production by stimulated human adult microglial cells in vitro. J Clin Invest (1996) 1.02
IL-10 production by adult human derived microglial cells. Neurochem Int (1996) 1.02
Caspase-3-mediated secretion of connective tissue growth factor by apoptotic endothelial cells promotes fibrosis. Cell Death Differ (2009) 1.01
Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Ann Neurol (1994) 1.01
Myelin basic protein and human coronavirus 229E cross-reactive T cells in multiple sclerosis. Ann Neurol (1996) 1.00
Linkage analysis in familial amyotrophic lateral sclerosis. Neurology (1989) 1.00
Neuropathy accompanying IgM lambda monoclonal gammopathy. Acta Neuropathol (1983) 1.00
N-arginine dibasic convertase (nardilysin) isoforms are soluble dibasic-specific metalloendopeptidases that localize in the cytoplasm and at the cell surface. Biochem J (2000) 0.99
CD40 engagement stimulates IL-12 p70 production by human microglial cells: basis for Th1 polarization in the CNS. J Neuroimmunol (2000) 0.98
Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci (1995) 0.98
Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro. Neurosurgery (1991) 0.97
Kinin B1 receptor expression and function on human brain endothelial cells. J Neuropathol Exp Neurol (2000) 0.96
Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Catalonia, Spain. Br J Cancer (2012) 0.95
Multiple sclerosis: magnetization transfer MR imaging of white matter before lesion appearance on T2-weighted images. Radiology (2000) 0.95
NRD convertase: a putative processing endoprotease associated with the axoneme and the manchette in late spermatids. J Cell Sci (1996) 0.94
Influence of azathioprine (imuran) on in vitro immune function in multiple sclerosis. Ann Neurol (1982) 0.94
Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. J Neuropathol Exp Neurol (2000) 0.93
Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy. Ann Neurol (1999) 0.93
p75 neurotrophin receptor expression on adult human oligodendrocytes: signaling without cell death in response to NGF. J Neurosci (1998) 0.93
Neutrophil-mediated cytotoxicity triggered by immune complexes: the role of reactive oxygen metabolites. Clin Exp Immunol (1987) 0.93
T cell regulation of polyclonally induced immunoglobulin secretion in humans. J Immunol (1984) 0.93
Inhibition of Th1 polarization by soluble TNF receptor is dependent on antigen-presenting cell-derived IL-12. J Immunol (1999) 0.92
Endovascular treatment of abdominal aneurysmal aortitis in Behçet's disease. J Vasc Surg (1998) 0.92
NK cell-mediated lysis of autologous human oligodendrocytes. J Neuroimmunol (2001) 0.92
[Arterial hypertension due to abuse of sympathomimetic drugs. One case (author's transl)]. Nouv Presse Med (1981) 0.92
Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat. Br J Pharmacol (1992) 0.92
Susceptibility of astrocytes to class I MHC antigen-specific cytotoxicity. J Immunol (1987) 0.92
Immunohistochemical studies of adult human glial cells. J Neuroimmunol (1989) 0.92
Assignment of tumor subtype by genomic testing and pathologic-based approximations: implications on patient's management and therapy selection. Clin Transl Oncol (2013) 0.92
Activated suppressor cell dysfunction in progressive multiple sclerosis. J Immunol (1986) 0.91
The efficacy of diflunisal in osteoarthritis of the knee. A Canadian Multicenter Study. J Rheumatol (1985) 0.91
Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C. Neurosurgery (1992) 0.90
A recovery model of partial cardiopulmonary bypass in the rat. Perfusion (2001) 0.90
Activation of adult human derived microglia by myelin phagocytosis in vitro. J Neurosci Res (1994) 0.89
Motor neuron disease: decremental responses to repetitive nerve stimulation. Neurology (1981) 0.89
Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis. AJNR Am J Neuroradiol (1999) 0.89
Reduced T-lymphocyte cell reactivity as a function of human aging. Cell Immunol (1980) 0.89